4,0
8. Feb. 2017
Mitarbeiter (anonym)
Ehemaliger Mitarbeiter, mehr als 10 Jahre
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Big vision Great capabilities Robust science Robust debate Strong desire to work with the most innovative field leaders, to patent and publish.
Kontras
Poor appraisal system (fair but VERY clunky and time consuming) Limited career opportunities Struggling with budget constraints given AZ's widely publicised issues with medicines coming off patent